Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1057)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
411
Price
$486.72
Total Value
$200.04K
Shares Held After
331,572
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$485.16
Total Value
$116.44K
Shares Held After
331,983
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$483.69
Total Value
$38.70K
Shares Held After
332,223
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$482.35
Total Value
$192.94K
Shares Held After
332,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$481.47
Total Value
$288.88K
Shares Held After
332,703
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$480.53
Total Value
$211.43K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$479.07
Total Value
$95.81K
Shares Held After
333,743
% of Holdings
0.1%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
61,888
Price
$11.16
Total Value
$690.39K
Shares Held After
1,473,194
% of Holdings
4.0%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
1,100
Price
$11.16
Total Value
$12.27K
Shares Held After
140,947
% of Holdings
0.8%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
36
Price
$25.81
Total Value
$929.16
Shares Held After
32,316
% of Holdings
0.1%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,207
Price
$26.01
Total Value
$83.42K
Shares Held After
32,352
% of Holdings
9.0%
Artiva Biotherapeutics, Inc. (ARTV)
Horan Christopher — Chief Tech Operations Officer
Shares
10,366
Price
$11.16
Total Value
$115.64K
Shares Held After
283,084
% of Holdings
3.5%
Artiva Biotherapeutics, Inc. (ARTV)
Bush Jennifer — COO, CLO, Compliance Officer
Shares
8,391
Price
$11.16
Total Value
$93.61K
Shares Held After
329,529
% of Holdings
2.5%
Editas Medicine, Inc. (EDIT)
O'Neill Gilmore Neil — Director
Shares
5,124
Price
$3.04
Total Value
$15.56K
Shares Held After
243,189
% of Holdings
2.1%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
129
Price
$25.77
Total Value
$3.32K
Shares Held After
27,362
% of Holdings
0.5%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
11,282
Price
$26.01
Total Value
$293.48K
Shares Held After
27,491
% of Holdings
29.1%
Editas Medicine, Inc. (EDIT)
Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Shares
709
Price
$3.04
Total Value
$2.15K
Shares Held After
61,660
% of Holdings
1.1%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
59
Price
$25.78
Total Value
$1.52K
Shares Held After
9,705
% of Holdings
0.6%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
5,130
Price
$26.01
Total Value
$133.45K
Shares Held After
9,764
% of Holdings
34.4%
Editas Medicine, Inc. (EDIT)
Parison Amy — SVP, Chief Financial Officer
Shares
453
Price
$3.04
Total Value
$1.38K
Shares Held After
13,839
% of Holdings
3.2%
Maze Therapeutics, Inc. (MAZE)
Courtney Phillips — GC and Corp. Secretary
Shares
22
Price
$25.78
Total Value
$567.16
Shares Held After
7,007
% of Holdings
0.3%
Maze Therapeutics, Inc. (MAZE)
Courtney Phillips — GC and Corp. Secretary
Shares
1,990
Price
$26.01
Total Value
$51.77K
Shares Held After
7,029
% of Holdings
22.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
McCourt Marion — EVP Commercial
Shares
1,131
Price
$857.39
Total Value
$969.71K
Shares Held After
12,003
% of Holdings
8.6%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
54
Price
$79.98
Total Value
$4.32K
Shares Held After
13,445
% of Holdings
0.4%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
2,339
Price
$79.98
Total Value
$187.07K
Shares Held After
312,989
% of Holdings
0.7%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
2,810
Price
$79.98
Total Value
$224.74K
Shares Held After
319,778
% of Holdings
0.9%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
32,263
Price
$7.17
Total Value
$231.33K
Shares Held After
4,144,952
% of Holdings
0.8%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
32,263
Price
$7.17
Total Value
$231.33K
Shares Held After
4,144,952
% of Holdings
0.8%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
10,000
Price
$208.65
Total Value
$2.09M
Shares Held After
0
% of Holdings
100.0%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$48.01
Total Value
$97.65K
Shares Held After
223,422
% of Holdings
0.9%
Kiniksa Pharmaceuticals International, plc (KNSA)
Megna Michael R — CHIEF ACCOUNTING OFFICER
Shares
4,600
Price
$80.30
Total Value
$369.38K
Shares Held After
29,062
% of Holdings
13.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
320
Price
$490.88
Total Value
$157.08K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
10
Price
$488.32
Total Value
$4.88K
Shares Held After
45,492
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
169
Price
$487.36
Total Value
$82.36K
Shares Held After
45,502
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
598
Price
$486.47
Total Value
$290.91K
Shares Held After
45,671
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
954
Price
$485.12
Total Value
$462.81K
Shares Held After
46,269
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
200
Price
$483.85
Total Value
$96.77K
Shares Held After
47,223
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
160
Price
$482.66
Total Value
$77.23K
Shares Held After
47,423
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,048
Price
$481.92
Total Value
$505.05K
Shares Held After
47,583
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,360
Price
$480.86
Total Value
$1.13M
Shares Held After
48,631
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
936
Price
$479.66
Total Value
$448.96K
Shares Held After
50,991
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,545
Price
$478.93
Total Value
$739.95K
Shares Held After
51,927
% of Holdings
2.9%
Denali Therapeutics Inc. (DNLI)
Thornberry Nancy — Director
Shares
615
Price
$23.74
Total Value
$14.60K
Shares Held After
19,686
% of Holdings
3.0%
Denali Therapeutics Inc. (DNLI)
Thornberry Nancy — Director
Shares
10,824
Price
$22.85
Total Value
$247.33K
Shares Held After
20,301
% of Holdings
34.8%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
656
Price
$2.75
Total Value
$1.80K
Shares Held After
114,805
% of Holdings
0.6%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
391
Price
$27.12
Total Value
$10.60K
Shares Held After
35,559
% of Holdings
1.1%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
2,800
Price
$26.38
Total Value
$73.85K
Shares Held After
35,950
% of Holdings
7.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
KIRITSY CHRISTOPHER P — Director
Shares
313
Price
$157.00
Total Value
$49.14K
Shares Held After
250
% of Holdings
55.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,375
Price
$27.12
Total Value
$37.29K
Shares Held After
38,773
% of Holdings
3.4%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
9,852
Price
$26.38
Total Value
$259.86K
Shares Held After
40,148
% of Holdings
19.7%
Showing 51–100 of 1057 transactions (page 2 of 22)